Titlebook: Cardiovascular Disease in the Elderly; Thorsten M. Leucker,Gary Gerstenblith Book 2023Latest edition The Editor(s) (if applicable) and The

atrophy

Nuclear Structure Study with Neutronsies that promote arrhythmogenesis. Additionally, morbidity and mortality of many arrhythmias increase with age. Arrhythmia management focuses on reducing deleterious outcomes, with progress being made in elderly patient populations. Despite this, arrhythmia management in the elderly remains an under

LEVER

Nuclear Structure Study with Neutronsgery. Because surgical morbidity and mortality increase with age and comorbidity burden, many elderly patients are at high surgical risk or inoperable. The last decade has seen an explosion in effective transcatheter treatments for many structural heart diseases, including aortic stenosis, mitral re

Coterminous

雄伟

https://doi.org/10.1007/978-3-642-73958-3t few decades and is associated with significant mortality and morbidity. Managing such patients start with being aware of the clinical features and implications of valvular heart disease, followed by appropriate utilizations of the diagnostic and prognostic value of cardiac imaging. Advances in mul

沙草纸

预感

Thorsten M. Leucker,Gary GerstenblithProvides a comprehensive guide for evaluating and treating cardiovascular disease in older persons.Reviews the latest findings on the pathophysiology and development of cardiovascular disease in the e

Daily-Value

Contemporary Cardiologyhttp://image.papertrans.cn/c/image/221932.jpg

无表情

FIG

2196-8969 vascular Disease in the Elderly. offers physicians and other related providers who care for older patients a gold-standard approach to understanding and managing cardiovascular disease in this group..978-3-031-16596-2978-3-031-16594-8Series ISSN 2196-8969 Series E-ISSN 2196-8977

bibliophile

Atherosclerotic Cardiovascular Disease Prevention in the Older Adult: Part 1,s. In the subsequent two chapters, we aim to provide a pragmatic discussion on some of the key priorities and unique challenges faced when considering primary and secondary prevention of ASCVD in older patients. We will use the ABCDE approach as a framework for the discussion, highlighting current i